Projects funded by the NCN
Importance of cyclin F-RRM2 axis in drug-resistance of melanoma cells with different degree of aggressiveness - in vitro studies
2016/21/B/NZ7/01121
Keywords:
melanoma cells cisplatin temozolomide UV radiation drug-resistance cyclin F RRM2
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_1: Cell biology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Lekarski
woj. kujawsko-pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 11 - announced on 2016-03-15
Amount awarded: 1 364 400 PLN
Project start date (Y-m-d): 2017-03-02
Project end date (Y-m-d): 2022-03-01
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.